Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia Pacific Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028

Published by Inkwood Research Product code 953129
Published Content info 111 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Extra Corporeal Membrane Oxygenation (Ecmo) System Market Forecast 2019-2028
Published: August 10, 2020 Content info: 111 Pages
Description

KEY FINDINGS

The Asia Pacific extra corporeal membrane oxygenation (ECMO) system market is predicted to register a CAGR of 5.07% during the estimated period, 2019-2028. The increasing prevalence of chronic, respiratory, and cardiovascular diseases, is driving the market growth.

MARKET INSIGHTS

India, Japan, China, Indonesia, Thailand, Australia & New Zealand, South Korea, Vietnam, and the rest of Asia Pacific, are evaluated in the assessment of the Asia Pacific extra corporeal membrane oxygenation (ECMO) system market growth. Japan is considered to be the largest medical device market in the Asia Pacific. The increasing cardiovascular diseases and growing medical expenditure majorly contribute to the growth of the Japanese market. There has been a rise in the prevalence of chronic respiratory diseases, with regard to several environmental factors like COPD and bronchial asthma. ECMO is one of the most highly advanced artificial organ treatments in the past decade. It has proved its efficiency in severe neonatal respiratory failure, thus becoming a standard treatment in Japan. One of the recent articles suggests that the Japanese Association for Acute Medicine, the Japanese Society of Respiratory Care Medicine, the PCPS/ECMO study group, and the Japanese Society of Intensive Care Medicine, have launched a COVID-19 ECMOnet working group.

In India, the rising healthcare expenditure and transplant surgeries, are the major factors fueling the market growth. There are 17 active ECMO centers active in the country, as per the ECMO society of India. One of the most common causes of ARDS in the country is pneumonia, followed by tropical infections. ECMO was started in India for postoperative cardiac cases. Its utility has gradually increased in the transplant unit, tracheobronchial surgery, and poisoning. Thus, India exhibits a promising graph for the ECMO market, in terms of both technology and cost-effectiveness.

COMPETITIVE INSIGHTS

Medtronic Plc, Livanova Plc, Microport Scientific Corporation, Nipro Corporation, Origen Biomedical Inc, are among the well-established companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 33025

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASED USAGE OF ECMO TECHNOLOGY
    • 3.2.2. TECHNOLOGICAL ADVANCEMENT
    • 3.2.3. GROWING BURDEN OF CHRONIC DISORDERS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF SPECIALIZED EXPERTISE
    • 3.3.2. HIGH COST OF ECMO SYSTEM
    • 3.3.3. SIDE EFFECTS RELATED TO THE ECMO SYSTEM
    • 3.3.4. PRESENCE OF CONVENTIONAL TECHNIQUES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY MODALITY

  • 5.1. VENO-VENOUS
  • 5.2. VENO-ARTERIAL
  • 5.3. OTHER MODALITIES

6. MARKET BY APPLICATION

  • 6.1. RESPIRATORY
  • 6.2. CARDIAC
  • 6.3. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

7. GEOGRAPHICAL ANALYSIS

  • 7.1. ASIA PACIFIC
    • 7.1.1. CHINA
    • 7.1.2. JAPAN
    • 7.1.3. INDIA
    • 7.1.4. AUSTRALIA & NEW ZEALAND
    • 7.1.5. SOUTH KOREA
    • 7.1.6. THAILAND
    • 7.1.7. INDONESIA
    • 7.1.8. VIETNAM
    • 7.1.9. REST OF ASIA PACIFIC

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. ALUNG TECHNOLOGIES INC
  • 8.3. ELSIUS BIOMEDICAL INC
  • 8.4. EUROSETS
  • 8.5. GETINGE AB
  • 8.6. LIVANOVA PLC
  • 8.7. MEDTRONIC PLC
  • 8.8. MICROPORT SCIENTIFIC CORPORATION
  • 8.9. NIPRO CORPORATION
  • 8.10. ORIGEN BIOMEDICAL INC
  • 8.11. SPECTRUM MEDICAL
  • 8.12. TERUMO MEDICAL CORPORATION
  • 8.13. XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM
  • TABLE 2: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIST OF CHRONIC DISEASES
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019
  • FIGURE 7: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019
  • FIGURE 11: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 16: JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 17: INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 18: AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 19: SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 20: THAILAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 21: INDONESIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 22: VIETNAM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: REST OF ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)
Back to Top